Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Potassium chloride; Sodium chloride
Fresenius Kabi Deutschland GmbH
B05BB; B05BB01
Potassium chloride; Sodium chloride
0.15% w/v + 0.9 percent weight/volume
Solution for infusion
Solutions affecting the electrolyte balance; electrolytes
Marketed
2014-11-03
PACKAGE LEAFLET: INFORMATION FOR THE USER POTASSIUM CHLORIDE 15% W/V CONCENTRATE FOR SOLUTION FOR INFUSION Potassium chloride. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Potassium Chloride is and what it is used for 2. What you need to know before you use Potassium Chloride 3. How to use Potassium Chloride 4. Possible side effects 5. How to store Potassium Chloride 6. Contents of the pack and other information 1. WHAT POTASSIUM CHLORIDE IS AND WHAT IT IS USED FOR This product belongs to the group “Additives for intravenous solutions’: Electrolytic solutions” and it is dispensed under medical prescription. Potassium Chloride is indicated for the treatment of potassium deficiency in patients for whom dietary measures or oral medication are inadequate. You must talk to a doctor if you do not feel better or if you feel worse. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE POTASSIUM CHLORIDE DO NOT USE POTASSIUM CLORIDE: You must not be given Potassium Chloride if you suffer from excess of potassium in the blood (hyperkalaemia). WARNINGS AND PRECAUTIONS Talk to your doctor before using Potassium Chloride. Potassium Chloride will be given by or under the direct supervision of your physician, who will take care for the following: - Direct injection of potassium chloride concentrates without appropriate dilution may cause instant death. - The administration should be slow (usually 10 mmol/hr, not exceeding 20 mmol/hr) and under control of cardiac activity. - Since adequate urine flow must be ens Read the complete document
Health Products Regulatory Authority 17 April 2019 CRN008S1T Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Potassium Chloride 0.15% w/v & Sodium Chloride 0.9% w/v Solution for Infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Potassium Chloride 1.50 g/l Sodium Chloride 9.00 g/l Each ml contains 1.50 mg potassium chloride and 9.00 mg sodium chloride. Each 500 ml bottle contains 0.75 g potassium chloride and 4.5 g sodium chloride. Each 1000 ml bottle contains 1.50 g potassium chloride and 9.00 g sodium chloride. mmol/l: K + : 20Na + : 154 Cl - : 174 For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for infusion Clear and colourless solution, free from visible particles Osmolarity: 348 mOsm/l (approx.) pH: 4.5 – 7.0 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Potassium Chloride 0.15% w/v & Sodium Chloride 0.9% w/v is indicated for the prevention and treatment of potassium depletion and/or hypokalaemia, in sodium chloride and water-losing conditions. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Doses may be expressed in terms of mEq or mmol of each cation, mass of each cation, or mass of each cation salt: - for sodium 1 g NaCl = 394 mg of Na + or 17.1 mEq or 17.1 mmol of Na + and Cl – 1 mmol Na + = 23 mg Na + - for potassium 1 g KCl = 525 mg of K + or 13.4 mEq or 13.4 mmol of K + and Cl – 1 mmol K + = 39.1 mg K + The dosage of this solution depends on the age, weight, clinical and biological (acid-base balance) conditions of the patient, concomitant therapy and in particular the patient's hydration state. _General posology _ The recommended dosage for treatment of isotonic fluid depletion (extracellular dehydration) by means of any intravenous solution is: - for adults: 500 ml to 3 litres/24 h - for babies and children: 20 to 100 ml per 24 h and per kg of body weight, depending of the age and the total body mass. Posology - Adults, Older people and Adolescents: Typical dose of potassium for the prevention of hypokalaemia may be up to 50 mmol Read the complete document